RABBIT COLLAGENASE GENE REGULATION BY IL-1
IL-1 对兔胶原酶基因的调控
基本信息
- 批准号:2732804
- 负责人:
- 金额:$ 3.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The long term goal of this research is to gain a detailed
understanding of the molecular mechanisms that regulate collagenase
(matrix metalloproteinase 1, MMP-1) expression in response to IL- 1.
IL-1 is a potent physiological inducer of collagenase mRNA, and under
pathological conditions collagenase, the only enzyme capable to
degrade interstitial collagens at neutral pH, is instrumental in
cartilage destruction in rheumatoid arthritis. Because of the central
role IL-1 plays in the pathophysiology of connective tissue breakdown
it is an important area of investigation. An understanding of the
transcriptional and post-transcriptional mechanisms may influence the
development of therapies designed to abrogate IL-1 induced
collagenase gene expression. Therefore, the transcriptional and post-
transcriptional mechanisms that regulate collagenase gene expression
in response to IL-1 will be investigated using a rabbit model of
synovial fibroblast cultures. Both experimentally and on the
nucleotide sequence level this model mimics primary cultures of human
cells from patients with rheumatoid arthritis. IL-1 responsive
elements in the rabbit collagenase gene will be identified by
transient transfection reporter constructs and deletional/mutational
analysis. The dependency of these fragments on sequences in the
proximal promoter, including AP-1 sites will be investigated.
Specific DNA/protein interactions occurring on these elements will be
investigated using electrophoretic mobility shift analysis,
antibodies for specific transcription factors and UV crosslinking.
RNA/protein interaction occurring at the 3' untranslated region of
the collagenase mRNA will be determined by the ability of native or
mutated AUUUA sequences to mediate binding of proteins from IL-1
treated and untreated cells.
这项研究的长期目标是获得一个详细的
对胶原酶调控分子机制的认识
(基质金属蛋白酶1,MMP-1)表达对IL-1的反应。
IL-1是胶原酶信使核糖核酸的有效生理诱导剂。
病理条件下,胶原酶是唯一能够
在中性pH下降解间质胶原蛋白,有助于
类风湿性关节炎的软骨破坏。因为中央
IL-1在结缔组织破裂的病理生理学中的作用
这是一个重要的调查领域。对这一概念的理解
转录和转录后机制可能会影响
旨在消除IL-1诱导的治疗方法的发展
胶原酶基因的表达。因此,转录和后转录-
胶原酶基因表达调控的转录机制
对IL-1的反应将使用兔模型进行研究
滑膜成纤维细胞培养。无论是在实验上还是在
核苷酸序列水平这个模型模拟了人类的原代培养
来自类风湿性关节炎患者的细胞。IL-1应答
兔胶原酶基因中的元件将通过
瞬时转染报告基因的构建与缺失/突变
分析。这些片段对序列的依赖性
近端启动子,包括AP-1位点将被调查。
在这些元素上发生的特定DNA/蛋白质相互作用将是
使用电泳迁移率变化分析进行研究,
针对特定转录因子和紫外线交联物的抗体。
RNA3‘端非翻译区与蛋白质的相互作用
胶原酶的mR-NA将由天然的或天然的
突变的AUUA序列介导IL-1蛋白的结合
处理过的和未处理过的细胞。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Invasion assays and matrix metalloproteinases. Quantification of cellular invasion using propidium iodide labeling and confocal laser scanning microscopy.
侵袭测定和基质金属蛋白酶。
- DOI:10.1385/1-59259-046-2:485
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Benbow,U;Orndorff,KA;Givan,AL
- 通讯作者:Givan,AL
Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells
- DOI:10.1002/(sici)1097-4644(19970901)66:3<322::aid-jcb5>3.3.co;2-d
- 发表时间:1997-09-01
- 期刊:
- 影响因子:4
- 作者:Rutter, JL;Benbow, U;Brinckerhoff, CE
- 通讯作者:Brinckerhoff, CE
Confocal assay for invasion: Use of propidium iodide fluorescence and laser reflectance to quantify the rate of migration of cells through a matrix
- DOI:10.1002/1097-0320(20000801)40:4<253::aid-cyto1>3.3.co;2-d
- 发表时间:2000-08-01
- 期刊:
- 影响因子:0
- 作者:Benbow, U;Orndorff, KA;Givan, AL
- 通讯作者:Givan, AL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ULRIKE BENBOW其他文献
ULRIKE BENBOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ULRIKE BENBOW', 18)}}的其他基金
相似海外基金
DNA glycosylases involved in interstrand crosslink repair and antibiotic self-resistance
DNA糖基化酶参与链间交联修复和抗生素自身抗性
- 批准号:
2341288 - 财政年份:2024
- 资助金额:
$ 3.05万 - 项目类别:
Standard Grant
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2335208 - 财政年份:2023
- 资助金额:
$ 3.05万 - 项目类别:
Continuing Grant
CAREER: Uncovering Mechanisms of DNA-protein Crosslink Repair
职业:揭示 DNA-蛋白质交联修复机制
- 批准号:
2146384 - 财政年份:2022
- 资助金额:
$ 3.05万 - 项目类别:
Continuing Grant
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2022
- 资助金额:
$ 3.05万 - 项目类别:
Postgraduate Scholarships - Doctoral
A molecular and structural approach to understanding interstrand crosslink incision by the Fanconi anaemia DNA repair pathway
通过分子和结构方法了解 Fanconi 贫血 DNA 修复途径的链间交联切口
- 批准号:
MR/X000192/1 - 财政年份:2022
- 资助金额:
$ 3.05万 - 项目类别:
Research Grant
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10446610 - 财政年份:2022
- 资助金额:
$ 3.05万 - 项目类别:
Regulation of SPRTN protease and SPRTN-mediated DNA-Protein Crosslink Repair
SPRTN 蛋白酶的调节和 SPRTN 介导的 DNA-蛋白质交联修复
- 批准号:
10641893 - 财政年份:2022
- 资助金额:
$ 3.05万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10438886 - 财政年份:2021
- 资助金额:
$ 3.05万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10296087 - 财政年份:2021
- 资助金额:
$ 3.05万 - 项目类别:
Investigating the molecular mechanism of SNM1A nuclease in DNA interstrand crosslink repair
研究SNM1A核酸酶在DNA链间交联修复中的分子机制
- 批准号:
548157-2020 - 财政年份:2021
- 资助金额:
$ 3.05万 - 项目类别:
Postgraduate Scholarships - Doctoral














{{item.name}}会员




